The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
SOCIETY: AASLD Join AASLD for an enlightening session where experts delve into groundbreaking research at the intersection of microbiome science and liver health. Participants will explore the profound impact of alcohol on liver health and how the microbiome plays a pivotal role in treating alcohol-associated liver diseases. By attending this program, attendees can expect to gain valuable knowledge and practical insights that will positively impact their research, clinical practice, and approach to liver health and disease. Please note that this session requires an additional registration fee to attend.
METABOLIC OUTCOMES AND KEY EFFICACY DATA FROM A PHASE 2 TRIAL EVALUATING COMBINATION OBETICHOLIC ACID AND BEZAFIBRATE IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS
ASSOCIATION OF GLUCAGON-LIKE PEPTIDE-1 AGONISTS WITH CIRRHOSIS AND HEPATOCELLULAR CANCER IN METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE (MASLD)